Search Results - "MILORADOVIC, Lena"
-
1
Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
Published in Clinical cancer research (15-03-2009)“…Purpose: NY-ESO-1 is a highly immunogenic antigen expressed in a variety of malignancies, making it an excellent target for cancer vaccination. We recently…”
Get full text
Journal Article -
2
Recombinant NY-ESO-1 Protein with ISCOMATRIX Adjuvant Induces Broad Integrated Antibody and CD4+ and CD8+ T Cell Responses in Humans
Published in Proceedings of the National Academy of Sciences - PNAS (20-07-2004)“…NY-ESO-1 is a "cancer-testis" antigen expressed in many cancers. ISCOMATRIX is a saponin-based adjuvant that induces antibody and T cell responses. We…”
Get full text
Journal Article -
3
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
Published in Blood (15-03-2005)“…Dendritic cells (DCs) are being evaluated for cancer immunotherapy due to their unique ability to induce tumor-directed T-cell responses. Here we report that…”
Get full text
Journal Article -
4
Immunodominant CD4+Responses Identified in a Patient Vaccinated with Full-Length NY-ESO-1 Formulated with ISCOMATRIX Adjuvant
Published in Proceedings of the National Academy of Sciences - PNAS (22-06-2004)“…There is increasing evidence showing the involvement of CD4+T cells in initiating and maintaining antitumor immune responses. NY-ESO-1 is expressed by various…”
Get full text
Journal Article -
5
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant
Published in Immunotherapy (01-03-2017)“…Pilot clinical trial of NY-ESO-1 (ESO) protein in ISCOMATRIX™ adjuvant pulsed onto peripheral blood dendritic cells (PBDC), to ascertain feasibility, evaluate…”
Get full text
Journal Article -
6
Systematic Analysis of Anti-NY-ESO-1 T Cell Responses Reveals Striking HLA-Dependent Immunodominance
Published in Journal of immunotherapy (1997) (01-11-2005)Get full text
Journal Article -
7
The Removal of Viruses During the Purification of Equine Antisera using Filtration Aids Hyflo Super-Cel™ and Fulmont™ Super A
Published in Biologicals (01-09-2000)“…The manufacturing process in Australia for equine antisera against various venoms/toxins is based primarily on ammonium sulphate precipitation of…”
Get full text
Journal Article